Skip to main content

Advertisement

SpringerLink
Log in

Pure Autonomic Failure

  • Autonomic Dysfunction (LH Weimer, Section Editor)
  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

Pure autonomic failure (PAF) is a rare sporadic neurodegenerative autonomic disorder characterized by slowly progressive pan autonomic failure without other features of neurologic dysfunctions. The main clinical symptoms result from neurogenic orthostatic hypotension and urinary and gastrointestinal autonomic dysfunctions. Autonomic failure in PAF is caused by neuronal degeneration of pre- and postganglionic sympathetic and parasympathetic neurons in the thoracic spinal cord and paravertebral autonomic ganglia. The presence of Lewy bodies and α-synuclein deposits in these neural structures suggests that PAF is one of Lewy body synucleinopathies, examples of which include multiple system atrophy, Parkinson disease, and Lewy body disease. There is currently no specific treatment to stop progression in PAF. Management of autonomic symptoms is the mainstay of treatment and includes management of orthostatic hypotension and supine hypertension. The prognosis for survival of PAF is better than for the other synucleinopathies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Bradbury S, Eggleston C. Postural hypotension: a report of three cases. Am Heart J. 1925;1:73–86.

    Article  Google Scholar 

  2. Garland E, Hooper W, Robertson D. Pure autonomic failure. Handb Clin Neurol. 2013;117:243–7.

    Article  PubMed  Google Scholar 

  3. Oppenheimer DR. Lateral horn cells in progressive autonomic failure. J Neurol Sci. 1980;46:393–404.

    Article  CAS  PubMed  Google Scholar 

  4. Matthews MR. Assessing the peripheral ganglia in autonomic failure. In: Bannister R, editor. Autonomic Failure. A textbook of clinical disorders of the autonomic nervous system. 2nd ed. Oxford: Oxford University Press; 1988. p. 511–43.

    Google Scholar 

  5. Goldstein DS, Polinsky RJ, Gatty M, Robertson D, Brown RT, Biaggioni I, et al. Patterns of plasma levels of catechols in neurogenic orthostatic hypotension. Ann Neurol. 1989;26:558–63.

    Article  CAS  PubMed  Google Scholar 

  6. Van Ingelghem E, van Zandijcke M, Lammens M. Pure autonomic failure: a new case with clinical, biochemical, and necropsy data. J Neurol Neurosurg Psychiatry. 1994;57:745–7.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Hague K, Lento P, Morgello S, Caro S, Kaufmann H. The distribution of Lewy bodies in pure autonomic failure: autopsy findings and review of the literature. Acta Neuropathol. 1997;94:192–6.

    Article  CAS  PubMed  Google Scholar 

  8. Arai K, Kato N, Kashiwado K, Hattori T. Pure autonomic failure in association with human a-synucleinopathy. Neurosci Lett. 2000;296:171–3.

    Article  CAS  PubMed  Google Scholar 

  9. Kaufmann H, Hague K, Perl D. Accumulation of alpha-synuclein in autonomic nerves in pure autonomic failure. Neurology. 2001;56:980–1.

    Article  CAS  PubMed  Google Scholar 

  10. Mathias C, Mallipeddi R, Bleasdale-Barr K. Symptoms associated with orthostatic hypotension in pure autonomic failure and multiple system atrophy. J Neurol. 1999;246:893–8.

    Article  CAS  PubMed  Google Scholar 

  11. Bleadales-Barr K, Mathias C. Neck and other muscle pains in autonomic failure: their association of orthostatic hypotension. J R Soc Med. 1998;91:355–9.

    Google Scholar 

  12. Smith GDP, Mathias C. Postural hypotension enhanced by exercise in patients with chronic autonomic failure. Q J Med. 1995;88:251–6.

    CAS  Google Scholar 

  13. Mathias CJ, Holly E, Armstrong E, Shareef M, Bannister R. The influence of food on postural hypotension in three groups with chronic autonomic failure clinical and therapeutic implications. J Neurol Neurosurg Psychiatry. 1991;54:726–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Caronna JJ, Plum F. Cerebrovascular regulation in preganglionic and postganglionic autonomic insufficiency. Stroke. 1973;4:12–9.

    Article  CAS  PubMed  Google Scholar 

  15. Brooks DJ, Redmond S, Mathias CJ, Bannister R, Symon L. The effect of orthostatic hypotension on cerebral blood flow and middle cerebral artery velocity in autonomic failure, with observations on the action of ephedrine. J Neurol Neurosurg Psychiatry. 1989;52:962–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Gurevich T, Gur AY, Bornstein NM, Giladi N, Korczyn AD. Cerebral vasomotor reactivity in Parkinson's disease, multiple system atrophy and pure autonomic failure. J Neurol Sci. 2006;243:57–60.

    Article  PubMed  Google Scholar 

  17. Shannon J, Jordan J, Costa F, Robertson RM, Biaggioni I. The hypertension of autonomic failure and its treatment. Hypertension. 1997;30:1062–7.

    Article  CAS  PubMed  Google Scholar 

  18. Vagaonescu TD, Saadia D, Turhim S, Phillips RA, Kaufmann H. Hypertensive cardiovascular damage in patient with primary autonomic failure. Lancet. 2000;355:725–6.

    Article  CAS  PubMed  Google Scholar 

  19. Garland E, Gamboa A, Okamato L, Raj S, Black B, Davis T, et al. The renal impairment of pure autonomic failure. Hypertension. 2009;54:1057–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Struhal W, Lahrmann H, Mathias C. Incidence of cerebrovascular lesions in pure autonomic failure. Incidence of cerebrovascular lesions in pure autonomic failure. Auton Neurosci. 2013;179:159–62.

    Article  PubMed  Google Scholar 

  21. Shannon J, Jordan J, Diedrich A, Pohar B, Black B, Robertson D, et al. Sympathetically mediated hypertension in autonomic failure. Circulation. 2000;101:2710–5.

    Article  CAS  PubMed  Google Scholar 

  22. Sakakibara R, Hattori T, Uchiyama T, Asahina M, Yamanishi T. Micturitional disturbance in pure autonomic failure. Neurology. 2000;54:499–501.

    Article  CAS  PubMed  Google Scholar 

  23. Yamanaka Y, Sakakibara R, Asahina M, Uchiyama T, Liu Z, Yamamoto T, et al. Chronic intestinal pseudo-obstruction as the initial feature of pure autonomic failure. J Neurol Neurosurg Psychiatry. 2006;77:800.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Idiaquez J, Fadic R, Verdugo R, Idiaquez JF, Iodice V, Low DA, et al. Pure autonomic failure with cold induced sweating. Auton Neurosci. 2013;176:98–100.

    Article  PubMed  Google Scholar 

  25. Weyer A, Minnerop M, Abele M, Klockgether T. REM sleep behavioral disorder in pure autonomic failure (PAF). Neurology. 2006;66:608–9.

    Article  PubMed  Google Scholar 

  26. Bremner F, Smith S. Pupil findings in a consecutive series of 150 patients with generalised autonomic neuropathy. J Neurol Neurosurg Psychiatry. 2006;77:1163–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Silveira-Moriyama L, Mathias C, Mason L, Best C, Quinn NP, Lees AJ. Hyposmia in pure autonomic failure. Neurology. 2009;72:1677–81.

    Article  CAS  PubMed  Google Scholar 

  28. Goldstein DS, Sewell L. Olfactory dysfunction in pure autonomic failure: implications for the pathogenesis of Lewy body diseases. Parkinsonism Relat Disord. 2009;15:516–20.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Braak H, Ghebremedhin E, Rüb U, Bratzke H, Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res. 2004;318:121–34.

    Article  PubMed  Google Scholar 

  30. Heims HC, Critchley HD, Martin NH, Jäger HR, Mathias CJ, Cipolotti L. Cognitive functioning in orthostatic hypotension due to pure autonomic failure. Clin Auton Res. 2006;16:113–20.

    Article  PubMed  Google Scholar 

  31. Johnson RH, Lee Gde J, Oppenheimer DR, Spalding JM. Autonomic failure with orthostatic hypotension due to intermediolateral column degeneration. A report of two cases with autopsies. Q J Med. 1966;35:276–92.

    CAS  PubMed  Google Scholar 

  32. Bannister R, Crowe R, Eames R, Burnstock G. Adrenergic innervation in autonomic failure. Neurology. 1981;31:1501–6.

    Article  CAS  PubMed  Google Scholar 

  33. Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci U S A. 1998;95:6469–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Kaufmann H, Goldstein DS. Pure autonomic failure: a restricted Lewy body synucleinopathy or early Parkinson disease? Neurology. 2010;74:536–7.

    Article  PubMed  Google Scholar 

  35. Donadio V, Incensi A, Cortelli P, Giannoccaro MP, Jaber MA, Baruzzi A, et al. Skin sympathetic fiber α-synuclein deposits: a potential biomarker for pure autonomic failure. Neurology. 2013;80:725–32. Donadio et al demonstrated phosphorylated a-synuclein in the skin sympathetic nerves and suggested that a-synuclein could be in vivo biomarker for PAF.

    Article  CAS  PubMed  Google Scholar 

  36. Wang N, Gibbons CH, Lafo J, Freeman R. α-Synuclein in cutaneous autonomic nerves. Neurology. 2013;81:1604–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Donadio V, Incensi A, Piccinini C, Cortelli P, Giannoccaro MP, Baruzzi A, et al. Skin nerve misfolded α-synuclein in pure autonomic failure and Parkinson disease. Ann Neurol. 2016;79:306–16.

    Article  CAS  PubMed  Google Scholar 

  38. Masuda H, Asahina M, Oide T, Wakita H, Sekiguchi Y, Araki N, et al. Antemortem detection of colonic α-synuclein pathology in a patient with pure autonomic failure. J Neurol. 2014;261:2451–2.

    Article  PubMed  Google Scholar 

  39. Kanda T, Tomimitsu H, Yokota T, Ohkoshi N, Hayashi M, Mizusawa H. Unmyelinated nerve fibers in sural nerve in pure autonomic failure. Ann Neurol. 1998;43:267–71.

    Article  CAS  PubMed  Google Scholar 

  40. Donadio V, Cortelli P, Elam M, Di Stasi V, Montagna P, Holmberg B, et al. Autonomic innervation in multiple system atrophy and pure autonomic failure. J Neurol Neurosurg Psychiatry. 2010;81:1327–35.

    Article  CAS  PubMed  Google Scholar 

  41. Low PA, Sletten DM. Laboratory evaluation of autonomic failure. In: Low PA, Benarroch EE, editors. Clinical autonomic disorders. 3rd ed. Baltimore: Lippincott Williams; 2008. p. 130–63.

    Google Scholar 

  42. Cohen J, Low P, Fealey R, Sheps S, Jiang NS. Somatic and autonomic function in progressive autonomic failure and multiple system atrophy. Ann Neurol. 1987;22:692–9.

    Article  CAS  PubMed  Google Scholar 

  43. Meredith IT, Eisenhofer G, Lambert GW, Jennings GL, Thompson J, Esler MD. Plasma norepinephrine responses to head-up tilt are misleading in autonomic failure. Hypertension. 1992;19:628–33.

    Article  CAS  PubMed  Google Scholar 

  44. Meredith IT, Esler MD, Cox HS, Lambert GW, Jennings GL, Eisenhofer G. Biochemical evidence of sympathetic denervation of the heart in pure autonomic failure. Clin Auton Res. 1991;1:187–94.

    Article  CAS  PubMed  Google Scholar 

  45. Goldstein DS. Imaging studies in chronic autonomic disorders. In: Low PA, Benarroch EE, editors. Clinical autonomic disorders. 3rd ed. Baltimore: Lippincott Williams & Wilkins; 2008. p. 336–44.

    Google Scholar 

  46. Yoshida M, Fukumoto Y, Kuroda Y, Ohkoshi N. Sympathetic denervation of myocardium demonstrated by 123I-MIBG scintigraphy in pure progressive autonomic failure. Eur Neurol. 1997;38:291–6.

    Article  CAS  PubMed  Google Scholar 

  47. Tipre DN, Goldstein DS. Cardiac and extracardiac sympathetic denervation in Parkinson's disease with orthostatic hypotension and in pure autonomic failure. J Nucl Med. 2005;46:1775–81.

    CAS  PubMed  Google Scholar 

  48. Braune S, Reinhardt M, Bathmann J, Krause T, Lehmann M, Lücking CH. Impaired cardiac uptake of meta-[123I]iodobenzylguanidine in Parkinson's disease with autonomic failure. Acta Neurol Scand. 1998;97:307–14.

    Article  CAS  PubMed  Google Scholar 

  49. Druschky A, Hilz MJ, Platsch G, Radespiel-Tröger M, Druschky K, Kuwert T, et al. Differentiation of Parkinson's disease and multiple system atrophy in early disease stages by means of I-123-MIBG-SPECT. J Neurol Sci. 2000;175:3–12.

    Article  CAS  PubMed  Google Scholar 

  50. Orimo S, Oka T, Miura H, Tsuchiya K, Mori F, Wakabayashi K, et al. Sympathetic cardiac denervation in Parkinson's disease and pure autonomic failure but not in multiple system atrophy. J Neurol Neurosurg Psychiatry. 2002;73:776–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Peeraully T. Multiple system atrophy. Semin Neurol. 2014;34:174–81. An in-depth updated review on MSA.

    Article  PubMed  Google Scholar 

  52. Kaufmann H, Oribe E, Miller M, Knott P, Wiltshire-Clement M, Yahr MD. Hypotension-induced vasopressin release distinguishes between pure autonomic failure and multiple system atrophy with autonomic failure. Neurology. 1992;42:590–3.

    Article  CAS  PubMed  Google Scholar 

  53. Schroeder C, Jordan J, Kaufmann H. Management of neurogenic orthostatic hypotension in patients with autonomic failure. Drugs. 2013;73:1267–79. A very comprehensive review of management of neurogenic orthostatic hypotension.

    Article  PubMed  Google Scholar 

  54. Low PA. Neurogenic orthostatic hypotension: pathophysiology and diagnosis. Am J Manag Care. 2015;21:s248–57. A very updated review on pathophysiology of neurogenic orthostatic hypotension.

    PubMed  Google Scholar 

  55. Figueroa JJ, Singer W, Sandroni P, Sletten DM, Gehrking TL, Gehrking JA, et al. Effects of patient-controlled abdominal compression on standing systolic blood pressure in adults with orthostatic hypotension. Arch Phys Med Rehabil. 2015;96:505–10.

    Article  PubMed  Google Scholar 

  56. Low PA, Fealey RD. Management of neurogenic orthostatic hypotension. In: Low PA, Benarroch EE, editors. Clinical autonomic disorders. 3rd ed. Baltimore: Lippincott Williams & Wilkins; 2008. p. 547–59.

    Google Scholar 

  57. Cruz DN. Midodrine: a selective alpha-adrenergic agonist for orthostatic hypotension and dialysis hypotension. Expert Opin Pharmacother. 2000;1:835–40.

    Article  CAS  PubMed  Google Scholar 

  58. Jankovic J, Gilden JL, Hiner BC, Kaufmann H, Brown DC, Coghlan CH, et al. Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine. Am J Med. 1993;95:38–48.

    Article  CAS  PubMed  Google Scholar 

  59. Low PA, Gilden JL, Freeman R, Sheng KN, McElligott MA. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group. JAMA. 1997;277:1046–51.

    Article  CAS  PubMed  Google Scholar 

  60. Wright RA, Kaufmann HC, Perera R, Opfer-Gehrking TL, McElligott MA, Sheng KN, et al. A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension. Neurology. 1998;51:120–4.

    Article  CAS  PubMed  Google Scholar 

  61. Singer W, Opfer-Gehrking TL, McPhee BR, Hilz MJ, Bharucha AE, Low PA. Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension. J Neurol Neurosurg Psychiatry. 2003;74:1294–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Singer W, Sandroni P, Opfer-Gehrking TL, Suarez GA, Klein CM, Hines S, et al. Pyridostigmine treatment trial in neurogenic orthostatic hypotension. Arch Neurol. 2006;63:513–8.

    Article  PubMed  Google Scholar 

  63. Chobanian AV, Volicer L, Tifft CP, Gavras H, Liang CS, Faxon D. Mineralocorticoid-induced hypertension in patients with orthostatic hypotension. N Engl J Med. 1979;301:68–73.

    Article  CAS  PubMed  Google Scholar 

  64. Loavenbruck A, Sandroni P. Neurogenic orthostatic hypotension: roles of norepinephrine deficiency in its causes, its treatment, and future research directions. Curr Med Res Opin. 2015;31:2095–104. Most updated and comprehensive on pathophysiology and management of neurogenic orthostatic hypotension.

    Article  PubMed  Google Scholar 

  65. Kaufmann H, Saadia D, Voustianiouk A, Goldstein DS, Holmes C, Yahr MD, et al. Norepinephrine precursor therapy in neurogenic orthostatic hypotension. Circulation. 2003;108:724–8.

    Article  CAS  PubMed  Google Scholar 

  66. Kaufmann H, Freeman R, Biaggioni I, Low P, Pedder S, Hewitt LA, et al. Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial. Neurology. 2014;83:328–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Childress AC, Berry SA. Pharmacotherapy of attention-deficit hyperactivity disorder in adolescents. Drugs. 2012;72:309–25.

    Article  CAS  PubMed  Google Scholar 

  68. Shibao C, Raj SR, Gamboa A, Diedrich A, Choi L, Black BK, et al. Norepinephrine transporter blockade with atomoxetine induces hypertension in patients with impaired autonomic function. Hypertension. 2007;50:47–53.

    Article  CAS  PubMed  Google Scholar 

  69. Perera R, Isola L, Kaufmann H. Effect of recombinant erythropoietin on anemia and orthostatic hypotension in primary autonomic failure. Clin Auton Res. 1995;5:211–3.

    Article  CAS  PubMed  Google Scholar 

  70. Winkler AS, Landau S, Watkins PJ. Erythropoietin treatment of postural hypotension in anemic type 1 diabetic patients with autonomic neuropathy: a case study of four patients. Diabetes Care. 2001;24:1121–3.

    Article  CAS  PubMed  Google Scholar 

  71. Trahair LG, Horowitz M, Jones KL. Postprandial hypotension: a systematic review. J Am Med Dir Assoc. 2014;15:394–409.

    Article  PubMed  Google Scholar 

  72. Ong AC, Myint PK, Potter JF. Pharmacological treatment of postprandial reductions in blood pressure: a systematic review. J Am Geriatr Soc. 2014;62:649–61.

    Article  PubMed  Google Scholar 

  73. Fanciulli A, Strano S, Colosimo C, Caltagirone C, Spalletta G, Pontieri FE. The potential prognostic role of cardiovascular autonomic failure in α-synucleinopathies. Eur J Neurol. 2013;20:231–5.

    Article  CAS  PubMed  Google Scholar 

  74. Goldstein DS, Holmes C, Sharabi Y, Wu T. Survival in synucleinopathies: a prospective cohort study. Neurology. 2015;85:1554–61. A new prospective study on survival analysis of many types of synucleinopathies.

    Article  CAS  PubMed  Google Scholar 

  75. Maule S, Milazzo V, Maule MM, Di Stefano C, Milan A, Veglio F. Mortality and prognosis in patients with neurogenic orthostatic hypotension. Funct Neurol. 2012;27:101–6.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurological Sciences, University of Nebraska Medical Center, 988435 Nebraska Medical Center, Omaha, NE, 68198-8435, USA

    Pariwat Thaisetthawatkul

Authors
  1. Pariwat Thaisetthawatkul
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pariwat Thaisetthawatkul.

Ethics declarations

Conflict of Interest

Pariwat Thaisetthawatkul declares no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Autonomic Dysfunction

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Thaisetthawatkul, P. Pure Autonomic Failure. Curr Neurol Neurosci Rep 16, 74 (2016). https://doi.org/10.1007/s11910-016-0673-2

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11910-016-0673-2

Keywords

Search

Navigation